Navigation Links
BioLife Solutions Appoints Raymond W. Cohen as Chairman and Joe Schick to Board of Directors
Date:11/19/2013

BOTHELL, Wash., Nov. 19, 2013 /PRNewswire/ -- BioLife Solutions, Inc. (OTCQB: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media for cells and tissues, and contract aseptic media manufacturer, today announced that it has appointed a new chairman of the board and also a new director.

Current board director Raymond Cohen was appointed non-executive Chairman of the Board, replacing Mike Rice, President & CEO, who remains in that role and on the board.  Cohen is currently the Chairman of the Board of Lombard Medical Technologies, PLC, a UK public medical device company.  He is also Chairman of the Board of JenaValve Technology, Inc., a privately held, Munich-based medical device company.  Cohen is also a director of Spectrum Pharmaceuticals, Syncroness, Inc., and LoneStar Heart, Inc. He was most recently the Chief Executive Officer of Vessix Vascular, Inc., and led its November 2012 acquisition by Boston Scientific, a deal valued at up to $425 million.

The Company also announced that Joe Schick, a senior financial leader for several high growth companies, has joined its board of directors, replacing Roderick de Greef, who resigned from the board to devote time to his personal interests.  Schick is currently the Chief Financial Officer of Corbis Corporation, a privately held global digital media company. Concurrent with
'/>"/>

SOURCE BioLife Solutions, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. BioLife Solutions Completes First $1 Million Revenue Quarter
2. BioLife Solutions Appoints Rick Stewart To Board of Directors
3. BioLife Solutions Announces 2012 Full Year Results; 10th Consecutive Quarter of Record Revenue
4. BioLife Solutions Announces Presentation at 8th World Stem Cells & Regenerative Medicine Congress
5. BioLife Solutions Announces the Addition of Robert Preti, Ph.D. to its Scientific Advisory Board
6. BioLife Solutions and SAVSU Technologies Announce Exclusive Distribution Agreement
7. BioLife Solutions Announces $2.2 million Total Revenue for the Third Quarter of 2013
8. SolutionStart Corp. Announces John Karagiannis as Vice President of Technology
9. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
10. At SIIM 2012 Siemens Healthcare Demonstrates Departmental IT Solutions That Help Administrators Increase Access while Managing Costs
11. Cardiosolutions, Inc. Receives FDA 510(k) Clearance for Dexterity™ Steerable Introducer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... 2015  Results from an interim analysis of ... 5g of idarucizumab enabled emergency surgery to be ... with dabigatran (Pradaxa ® dabigatran etexilate mesylate). The ... of dabigatran enabled patients to be urgently brought ... 1.7 hours between administration of idarucizumab and start ...
(Date:9/1/2015)... Sept. 1, 2015 Sargas Pharmaceutical Adherence ... and Drug Adherence m Health applications along with ... process of non face-to-face monitoring of twenty minutes ... release of our apps, doctors are now well ... with our ONCHIT certified Physician, Pharmacy and Patient ...
(Date:9/1/2015)... 2015 The global ... of sectors, products & services and application. And the ... the increasing demand of advanced drugs for the ... the growth for bioinformatics market. The implementation of ... known as bioinformatics. Decreasing cost of DNA sequencing, ...
Breaking Medicine Technology:New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 2New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 3New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 4New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 5New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 6New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 7New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 8New Analysis Shows Idarucizumab* Enables Rapid Initiation of Emergency Surgery in Dabigatran-Treated Patients 9SPAC International's Drug Adherence and Chronic Care Management App Now available at Apple App and Google Play stores 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4
... NORTHBROOK, Ill. , May 26 ... on the development and commercialization of innovative medicines ... its New Drug Application (NDA) for DUEXA®, a ... ibuprofen and high-dose famotidine, was accepted by the ...
... , , , ... The U.S. Food and Drug Administration announced today that it will collaborate with the Web ... , , ... Drugs.com seeks to provide patients ...
Cached Medicine Technology:Horizon Pharma, Inc. Announces FDA Acceptance of DUEXA(R) New Drug Application for Filing 2Horizon Pharma, Inc. Announces FDA Acceptance of DUEXA(R) New Drug Application for Filing 3Horizon Pharma, Inc. Announces FDA Acceptance of DUEXA(R) New Drug Application for Filing 4FDA Announces Collaboration With Drugs.com 2
(Date:9/1/2015)... WA (PRWEB) , ... September 01, 2015 , ... Philanthropic ... increasing awareness of societal issues and needs. Money for Good 2015, released today by ... solving it. There’s an annual potential to mobilize up to $22B in new philanthropic ...
(Date:9/1/2015)... ... September 01, 2015 , ... As part of its ... Shield of Minnesota (Blue Cross) has announced Doctor On Demand as the company’s ... Doctor On Demand provides immediate access to Board Certified physicians or next-day appointments ...
(Date:9/1/2015)... ... September 01, 2015 , ... OncLive® today announced ... News & World Report, to provide breaking news and information about the hospital’s ... within OncLive, which provides oncologists resources and information?they need to deliver the best ...
(Date:9/1/2015)... ... September 01, 2015 , ... Discovia, ... entities, announced today that it has hired Scott Sanderson, an experienced business development ... capacity, Sanderson will be responsible for establishing and managing new client relationships in ...
(Date:9/1/2015)... ... September 01, 2015 , ... The FSH Society , the ... muscular dystrophy (FSHD), will be the beneficiary of a collection of fundraising events this ... raise awareness of the FSH Society and further FSHD research. , The ...
Breaking Medicine News(10 mins):Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 2Health News:Camber Collective Releases Money for Good 2015 - Revealing Root Causes to Why Charitable Giving Has Been Stuck at 2% GDP Since the 70s 3Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 2Health News:Blue Cross and Blue Shield of Minnesota names Doctor On Demand as preferred telehealth destination 3Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 2Health News:OncLive® and Cleveland Clinic Team up to Provide News, Information About Cancer Research and Patient Care 3Health News:Former NFL Standout Scott Sanderson Joins eDiscovery Leader Discovia 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 2Health News:FSH Society Beneficiary of Variety of Fall Fundraising Events 3
... ... care optometric practice, is pleased to announce Dr. Emily S. Kachinsky as the newest ... eye care professionals, headed by Dr. Ronald M. Cline. Dr. Cline, owner of Randolph ... the South Shore and Greater Boston area. , ...
... , TUESDAY, June 29 (HealthDay News) -- American teenage girls ... in years past, a new report says. Girls appear more ... them emotionally, according to a survey by the nonprofit Partnership for ... high school students found 53 percent of girls agreeing with the ...
... sugar level sensor to an insulin pump helps patients with ... the common standard of care, multiple daily insulin injections, concludes ... Journal of Medicine . The paper is ... "Combining the best technologies for insulin delivery and ...
... ... Ready for Distribution to Natural Food Stores and Mainstream Supermarkets Coast-to-Coast. Made from a ... ... LLC, the parent company of MimicCreme®, announced today the release of its truly dairy-free, ...
... patient in four in Germany is in favor of ... in other nations are more satisfied. A working group ... and Efficiency in Health Care (Institut fr Qualitt und ... surveys carried out by the Commonwealth Fund in 2005 ...
... that getting older means losing a mental edge, leading to ... University shows that when it comes to making intuitive decisions ... well as their juniors. The researchers tested groups of ... meaning they live in the community, rather than in ...
Cached Medicine News:Health News:Randolph Eye Associates Continues Growth With the Addition of Dr. Emily S. Kachinsky , 2Health News:Randolph Eye Associates Continues Growth With the Addition of Dr. Emily S. Kachinsky , 3Health News:Teen Girls Becoming More Open to Drugs, Alcohol 2Health News:Teen Girls Becoming More Open to Drugs, Alcohol 3Health News:Sensor and insulin pump results in better blood-sugar control in all age groups with diabetes 2Health News:MimicCreme Announces the Release of its Dairy-Free Whipping Cream - HealthyTop and Two New Flavored Coffee Creamers. 2Health News:Study shows age doesn't necessarily affect decision-making 2
... a whole blood hematology control manufactured specifically ... 120, and the Coulter AcT5diff instruments. The ... white cell differential, positioning the populations within ... systems. The product offers 105-day closed-vial stability ...
... assayed hematology control, offers complete assay values ... with the Coulter GENS, STKS, MAXM and ... stability, 105-day closed-vial stability and is available ... 4.0ml pierceable cap vial is compatible with ...
Abiomed introduces its new intra-aortic balloon (IAB); an easy-to-insert, minimally invasive technology designed to enhance blood flow to the heart and other organs for patients with diminished heart...
Diagnosoft HARP is designed for rapid analysis of tagged cardiac MR images using the HARP technology, which is packaged into an intuitive, easy-to-use graphic user interface....
Medicine Products: